April 29, 2020 / By James Rogers | Fox News The experimental coronavirus treatment remdesivir has generated “positive data” in a trial of the antiviral organized by the National Institute of Allergy and Infectious Diseases (NIAID), according to developer Gilead Sciences. “We understand that the trial has met its primary endpoint and that NIAID will provide detailed information at an upcoming briefing,” …